8.19
price down icon1.33%   -0.11
after-market Dopo l'orario di chiusura: 8.40 0.21 +2.56%
loading

Perché le azioni Anavex Life Sciences Corporation (AVXL) sono in ribasso?

Abbiamo notato un calo di 6.53% nelle azioni di Anavex Life Sciences Corporation (AVXL) durante la sessione di negoziazione di 2025-04-01. Sebbene ciò possa essere attribuito alla normale volatilità o a vari fattori interni ed esterni, tieni presente che stiamo monitorando attivamente la situazione e forniremo aggiornamenti tempestivi il prima possibile!
2023-11-27:

Anavex Life Sciences Corporation Stock (AVXL) dropped by 10.04% from $7.07 to $6.36 in the trading on Monday November 27, 2023. The reasons why AVXL stock down today include:

  • Fourth-quarter financial results: Anavex Life Sciences reported a narrower net loss of $10.1 million for the fourth quarter of 2023, compared to $14.3 million in the year-ago quarter. The company's non-cash items decreased to $3.2 million from $6.0 million in the prior-year quarter, resulting in a net loss per share of 12 cents, down from 18 cents.
  • Shortage in key pipeline update: Anavex reported pipeline updates that excluded a clear timeline for one of its key development programs for lead drug blarcamesine. Without a specific timeline, the company said it is on track to release topline data from its ANAVEX 2-73-RS-003 Phase 2/3 EXCELLENCE clinical trial for blarcamesine in children with the neurological disorder Rett syndrome.
$60.58
price down icon 3.01%
$69.18
price down icon 5.66%
$17.36
price down icon 8.20%
$31.11
price down icon 2.14%
$88.05
price down icon 4.30%
biotechnology ONC
$238.51
price down icon 9.76%
Capitalizzazione:     |  Volume (24 ore):